Whipplewood Advisors’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$29.5K Sell
61
-260
-81% -$69K 0.02% 166
2026
Q1
$35.2K Buy
321
+319
+15,950% +$45.4K 0.02% 311
2025
Q4
$333 Buy
+2
New +$335 ﹤0.01% 479
2025
Q3
Sell
-607
Closed -$54.9K 1188
2025
Q2
$54.9K Sell
607
-7
-1% -$553 0.03% 309
2025
Q1
$20.5K Buy
614
+119
+24% +$11K 0.01% 447
2024
Q4
$65.6K Buy
+495
New +$46.5K 0.04% 274

Other funds holding ALAB

Whipplewood Advisors's ALAB Position: Q2 2026 in Review

Whipplewood Advisors reduced its Astera Labs (ALAB) stake by 81% in Q2 2026, selling an estimated $69K and leaving 61 shares worth $29.5K. The position accounts for 0.02% of the portfolio, ranked #166.

Whipplewood Advisors first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. The position peaked at $65.6K in Q4 2024. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Whipplewood Advisors held 61 shares of Astera Labs worth $29.5K as of Q2 2026.
  • Whipplewood Advisors sold 260 Astera Labs shares in Q2 2026, an estimated $69K.
  • Astera Labs made up 0.02% of Whipplewood Advisors's portfolio in Q2 2026, its #166 holding.
  • Whipplewood Advisors first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • Whipplewood Advisors's Astera Labs position peaked at $65.6K in Q4 2024.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Whipplewood Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.